Union Budget 2018 Reactions
The Union Budget 2018 evokes mixed reviews from the pharmaceuticals industry
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
ICMR, Pfizer to work on antimicrobial resistance
The ‘Centre to Combat Antimicrobial Resistance’ in New Delhi will be set up
Oracle Health Sciences launches cloud-based eClinical solution
Clinical One Platform unifies clinical development ops, info to increase speed to market at lower cost
Alembic’s Q3 Net profit up by 52%
The net profit was at Rs 131 crores against Rs 86 crores last year
Wockhardt reports net sales at Rs1,005 crore in Q3 FY18
EBITDA was at Rs. 45 crore which grew 6 times Q-o-Q and 2.5 times Y-o-Y
Ajanta pharma revenue up by 4 %
Q3 income from operations at Rs. 587 crore, PAT at Rs. 147 crore
Suven’s Revenue up by 11.85 %
PAT up by 15.38 per cent for 9 months ended in December’ 2017
Harish Salve to argue Ranbaxy’s case in Singapore
Top Indian lawyers to argue Ranbaxy-Daiichi appeal in S'pore By Gurdip Singh Singapore
Novartis India appoints Jawed Zia as VC and MD
His appointment is effective March 1, 2018
At a meeting held in Mumbai today, the Board of Directors of Novartis India announced…
Mylan, Biocon receive CHMP opinion for Semglee, biosimilar insulin glargine
Marketing applications for Semglee have been submitted in Australia, Canada, and the US and are planned for key emerging markets…
Strides Shasun receives US FDA approval
The company received the approval for Tenofovir Disoproxil Fumarate Tablets, 300 mg from the United States Food & Drug…
DRL features in Bloomberg Gender-Equality Index
The company has been recognised for its efforts in creating a work environment that supports gender equality
Cipla receives ANDA approval
The US FDA has granted final approval for Tenofovir Disoproxil Fumarate Tablets
Premas Life Sciences and IncellDx sign distribution agreement
It follows the successful study at AIIMS Institute utilising IncellDx's (3Dx) investigational molecular assay
Biocon Q3 FY18 revenue at Rs 1092 Crore
EBITDA at Rs 256 Crore; Net Profit at Rs 92 Crore
Glenmark presents preliminary biomarker data on GBR 1302
GBR 1302, a HER2xCD3 Bispecific Monoclonal Antibody, at the ASCO-SITC Clinical Immuno-Oncology Symposium
SABIC acquires 24.99% stake in Clariant
Clariant has acknowledges investment by chemical industry peer and partner SABIC
New Homeopathy Research Institute in Jaipur
AYUSH Minister lays foundation stone for Homeopathy Research Institute in Jaipur
Budget Predictions FY19: CARE Ratings
Govt could allocate more incentives to R&D to improve quality standards